Estrogen for Triple Negative Breast Cancer

NCT01083641 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped did not meet efficacy goals after interim analysis

Conditions

Female Breast Cancer

Interventions

DRUG: Estradiol

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]